Annual SGA
$169.82 M
+$8.96 M+5.57%
December 31, 2023
Summary
- As of February 8, 2025, PACB annual SGA is $169.82 million, with the most recent change of +$8.96 million (+5.57%) on December 31, 2023.
- During the last 3 years, PACB annual SGA has risen by +$97.02 million (+133.27%).
- PACB annual SGA is now at all-time high.
Performance
PACB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$43.75 M
-$2.13 M-4.65%
September 30, 2024
Summary
- As of February 8, 2025, PACB quarterly SGA is $43.75 million, with the most recent change of -$2.13 million (-4.65%) on September 30, 2024.
- Over the past year, PACB quarterly SGA has dropped by -$2.13 million (-4.65%).
- PACB quarterly SGA is now -4.89% below its all-time high of $46.00 million, reached on December 31, 2023.
Performance
PACB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$8.00 B
-$394.24 M-5.18%
September 30, 2024
Summary
- As of February 8, 2025, PACB TTM SGA is -$8.00 billion, with the most recent change of -$394.24 million (-5.18%) on September 30, 2024.
- Over the past year, PACB TTM SGA has dropped by -$8.18 billion (-4566.84%).
- PACB TTM SGA is now -4065.71% below its all-time high of -$192.00 million.
Performance
PACB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PACB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.6% | -4.7% | -4566.8% |
| 3 y3 years | +133.3% | +38.4% | -7734.9% |
| 5 y5 years | +167.5% | +118.0% | -10000.0% |
PACB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.8% | -4.9% | +18.9% | -71.8% | at low |
| 5 y | 5-year | at high | +133.3% | -4.9% | +196.1% | -91.3% | at low |
| alltime | all time | at high | +2579.4% | -4.9% | +1169.1% | -4065.7% | at low |
Pacific Biosciences Of California Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $43.75 M(-4.6%) | $179.37 M(+0.2%) |
| Jun 2024 | - | $45.88 M(+4.9%) | $179.06 M(+3.1%) |
| Mar 2024 | - | $43.75 M(-4.9%) | $173.75 M(+2.3%) |
| Dec 2023 | $169.82 M(+5.6%) | $46.00 M(+5.9%) | $169.82 M(+0.6%) |
| Sep 2023 | - | $43.43 M(+7.0%) | $168.82 M(+4.1%) |
| Jun 2023 | - | $40.57 M(+1.9%) | $162.19 M(+0.8%) |
| Mar 2023 | - | $39.82 M(-11.5%) | $160.87 M(+0.0%) |
| Dec 2022 | $160.85 M(+29.6%) | $45.00 M(+22.3%) | $160.85 M(+5.0%) |
| Sep 2022 | - | $36.80 M(-6.3%) | $153.17 M(+3.5%) |
| Jun 2022 | - | $39.25 M(-1.4%) | $147.98 M(+7.4%) |
| Mar 2022 | - | $39.80 M(+6.7%) | $137.79 M(+11.0%) |
| Dec 2021 | $124.12 M(+70.5%) | $37.32 M(+18.1%) | $124.13 M(+18.5%) |
| Sep 2021 | - | $31.61 M(+8.8%) | $104.76 M(+19.1%) |
| Jun 2021 | - | $29.06 M(+11.2%) | $87.92 M(+18.8%) |
| Mar 2021 | - | $26.14 M(+45.6%) | $73.99 M(+1.6%) |
| Dec 2020 | $72.80 M(-3.6%) | $17.95 M(+21.5%) | $72.80 M(+1.9%) |
| Sep 2020 | - | $14.77 M(-2.3%) | $71.42 M(-6.9%) |
| Jun 2020 | - | $15.13 M(-39.4%) | $76.72 M(-4.9%) |
| Mar 2020 | - | $24.95 M(+50.5%) | $80.67 M(+6.9%) |
| Dec 2019 | $75.49 M(+18.9%) | $16.58 M(-17.4%) | $75.49 M(-4.5%) |
| Sep 2019 | - | $20.07 M(+5.2%) | $79.02 M(+9.1%) |
| Jun 2019 | - | $19.08 M(-3.5%) | $72.46 M(+6.1%) |
| Mar 2019 | - | $19.77 M(-1.7%) | $68.32 M(+7.6%) |
| Dec 2018 | $63.49 M(+7.4%) | $20.11 M(+48.9%) | $63.49 M(+9.9%) |
| Sep 2018 | - | $13.51 M(-9.6%) | $57.78 M(-0.8%) |
| Jun 2018 | - | $14.94 M(+0.1%) | $58.23 M(-1.0%) |
| Mar 2018 | - | $14.93 M(+3.7%) | $58.79 M(-0.6%) |
| Dec 2017 | $59.12 M(+23.7%) | $14.40 M(+3.2%) | $59.12 M(+2.4%) |
| Sep 2017 | - | $13.95 M(-10.0%) | $57.72 M(+3.7%) |
| Jun 2017 | - | $15.51 M(+1.6%) | $55.66 M(+8.4%) |
| Mar 2017 | - | $15.27 M(+17.5%) | $51.34 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $47.79 M(+5.8%) | $12.99 M(+9.2%) | $47.79 M(+0.5%) |
| Sep 2016 | - | $11.89 M(+6.3%) | $47.57 M(+2.3%) |
| Jun 2016 | - | $11.19 M(-4.4%) | $46.49 M(+0.8%) |
| Mar 2016 | - | $11.71 M(-8.4%) | $46.12 M(+2.1%) |
| Dec 2015 | $45.19 M(+18.8%) | $12.78 M(+18.1%) | $45.19 M(+6.5%) |
| Sep 2015 | - | $10.82 M(-0.0%) | $42.41 M(+2.3%) |
| Jun 2015 | - | $10.82 M(+0.5%) | $41.48 M(+4.6%) |
| Mar 2015 | - | $10.77 M(+7.7%) | $39.65 M(+4.3%) |
| Dec 2014 | $38.03 M(-1.9%) | $10.00 M(+1.2%) | $38.03 M(+2.5%) |
| Sep 2014 | - | $9.88 M(+9.9%) | $37.09 M(-2.3%) |
| Jun 2014 | - | $8.99 M(-1.7%) | $37.96 M(-1.0%) |
| Mar 2014 | - | $9.15 M(+1.0%) | $38.34 M(-1.0%) |
| Dec 2013 | $38.74 M(-18.7%) | $9.06 M(-15.8%) | $38.74 M(-4.0%) |
| Sep 2013 | - | $10.76 M(+14.8%) | $40.35 M(+1.5%) |
| Jun 2013 | - | $9.37 M(-1.9%) | $39.74 M(-5.2%) |
| Mar 2013 | - | $9.55 M(-10.5%) | $41.92 M(-12.0%) |
| Dec 2012 | $47.66 M(+2.0%) | $10.67 M(+5.2%) | $47.66 M(-2.3%) |
| Sep 2012 | - | $10.14 M(-12.2%) | $48.80 M(-5.1%) |
| Jun 2012 | - | $11.56 M(-24.4%) | $51.42 M(+1.1%) |
| Mar 2012 | - | $15.29 M(+29.4%) | $50.88 M(+8.9%) |
| Dec 2011 | $46.71 M(+55.2%) | $11.81 M(-7.5%) | $46.71 M(+3.3%) |
| Sep 2011 | - | $12.76 M(+15.9%) | $45.23 M(+11.7%) |
| Jun 2011 | - | $11.02 M(-0.9%) | $40.51 M(+13.4%) |
| Mar 2011 | - | $11.12 M(+7.7%) | $35.71 M(+18.7%) |
| Dec 2010 | $30.09 M(+144.1%) | $10.33 M(+28.4%) | $30.09 M(+29.1%) |
| Sep 2010 | - | $8.04 M(+29.3%) | $23.30 M(+24.6%) |
| Jun 2010 | - | $6.22 M(+13.2%) | $18.70 M(+49.8%) |
| Mar 2010 | - | $5.50 M(+55.2%) | $12.48 M(+78.6%) |
| Dec 2009 | $12.33 M(+59.8%) | $3.54 M(+2.7%) | $6.99 M(+102.7%) |
| Sep 2009 | - | $3.45 M | $3.45 M |
| Dec 2008 | $7.71 M(+21.7%) | - | - |
| Dec 2007 | $6.34 M | - | - |
FAQ
- What is Pacific Biosciences of California annual SGA?
- What is the all time high annual SGA for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual SGA year-on-year change?
- What is Pacific Biosciences of California quarterly SGA?
- What is the all time high quarterly SGA for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly SGA year-on-year change?
- What is Pacific Biosciences of California TTM SGA?
- What is the all time high TTM SGA for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM SGA year-on-year change?
What is Pacific Biosciences of California annual SGA?
The current annual SGA of PACB is $169.82 M
What is the all time high annual SGA for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual SGA is $169.82 M
What is Pacific Biosciences of California annual SGA year-on-year change?
Over the past year, PACB annual SGA has changed by +$8.96 M (+5.57%)
What is Pacific Biosciences of California quarterly SGA?
The current quarterly SGA of PACB is $43.75 M
What is the all time high quarterly SGA for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly SGA is $46.00 M
What is Pacific Biosciences of California quarterly SGA year-on-year change?
Over the past year, PACB quarterly SGA has changed by -$2.13 M (-4.65%)
What is Pacific Biosciences of California TTM SGA?
The current TTM SGA of PACB is -$8.00 B
What is the all time high TTM SGA for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM SGA is -$192.00 M
What is Pacific Biosciences of California TTM SGA year-on-year change?
Over the past year, PACB TTM SGA has changed by -$8.18 B (-4566.84%)